1. Bian, Yibo, Xu, Shufen, Gao, Zhishuang, Pu, Juan, Wang, Keming. 2024. m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop. In Cancer letters, 596, 217004. doi:10.1016/j.canlet.2024.217004. https://pubmed.ncbi.nlm.nih.gov/38838765/
2. Lu, H, Zhu, C, Chen, Y, Chen, Q, Wei, Q. 2022. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 24, 1124-1133. doi:10.1007/s12094-021-02753-z. https://pubmed.ncbi.nlm.nih.gov/35098448/
3. Zhu, Duanrong, Hao, Qun, Qian, Min, Hu, Yuli, Wu, Feifei. 2022. LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future. In Journal of healthcare engineering, 2022, 8387458. doi:10.1155/2022/8387458. https://pubmed.ncbi.nlm.nih.gov/35186240/
4. Feng, W, Lai, Y, Wang, J, Xu, P. . [Long non-coding RNA ABHD11-AS1 promotes glycolysis in gastric cancer cells to accelerate tumor progression]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 43, 1485-1492. doi:10.12122/j.issn.1673-4254.2023.09.05. https://pubmed.ncbi.nlm.nih.gov/37814862/
5. Yang, Ting, Tian, Sijuan, Zhao, Juan, Zhao, Minyi, Yang, Xiaofeng. 2023. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA. In Cell cycle (Georgetown, Tex.), 22, 2538-2551. doi:10.1080/15384101.2023.2297591. https://pubmed.ncbi.nlm.nih.gov/38146687/
6. Lin, Guangyao, Ye, Tao, Wang, Jing. 2024. The association between long noncoding RNA ABHD11-AS1 and malignancy prognosis: a meta-analysis. In BMC cancer, 24, 1083. doi:10.1186/s12885-024-12866-7. https://pubmed.ncbi.nlm.nih.gov/39223500/
7. Hou, Sen, Zhuang, Yu-Ying, Lin, Qiu-Yu, Zhang, Laney, Lin, Cheng-He. 2021. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma. In Experimental and molecular pathology, 121, 104658. doi:10.1016/j.yexmp.2021.104658. https://pubmed.ncbi.nlm.nih.gov/34102210/
8. Hou, Shunyu, Zhang, Xiaoqian, Yang, Jian. 2021. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. In Experimental cell research, 410, 112929. doi:10.1016/j.yexcr.2021.112929. https://pubmed.ncbi.nlm.nih.gov/34793775/
9. Yang, Yunben, Shao, Yongfu, Zhu, Mengying, Sun, Yanke, Guo, Junming. 2015. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 1183-8. doi:10.1007/s13277-015-3903-3. https://pubmed.ncbi.nlm.nih.gov/26280398/
智鼠故事 
